Systematic overview of cost–effectiveness thresholds in ten countries across four continents

Ruth Schwarzer, Ursula Rochau, Kim Saverno, +13

Journal of Comparative Effectiveness Research

Concepts of ‘Personalization’ in Personalized Medicine: Implications for Economic Evaluation

Wolf Rogowski, Katherine Payne, Petra Schnell‐Inderst, +6

PharmacoEconomics

Healthcare ValueHealth EconomicsManagementPersonalized TreatmentPharmacoeconomics +6

Ensuring Effective Prevention of Iodine Deficiency Disorders

Henry Völzke, Philippe Caron, Lisbeth Dahl, +28

Thyroid

Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions

Stacy Loeb, Qinlian Zhou, Uwe Siebert, +6

European Urology

UrologyCancer DetectionCancer ScreeningLocalized Prostate CancerMedicine +6

Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis

Ursula Rochau, M. Kluibenschaedl, David D. Stenehjem, +5

Leukemia Research and Treatment

Nature-based social interventions for people experiencing loneliness: the rationale and overview of the RECETAS project

Jill Litt, Laura Coll‐Planas, Ashby Lavelle Sachs, +24

Cities & Health

Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia

Ursula Rochau, Gaby Sroczynski, Dominik Wolf‎, +9

Leukemia & lymphoma/Leukemia and lymphoma

Cost-effectiveness AnalysisMixed-phenotype Acute LeukemiaPharmacotherapyMyeloid NeoplasiaHematological Malignancy +15

Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online

Beate Jahn, Ursula Rochau, Christina Kurzthaler, +9

BMC Cancer

Nature-based social interventions to address loneliness among vulnerable populations: a common study protocol for three related randomized controlled trials in Barcelona, Helsinki, and Prague within the RECETAS European project

Laura Coll‐Planas, Aina Carbó-Cardeña, Anu Jansson, +16

BMC Public Health

Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics

Ella Willenbacher, Roman Weger, Ursula Rochau, +2

PLoS ONE